Oncotelic Therapeutics, Inc. Cash Provided by (Used in) Operating Activities, Discontinued Operations
Oncotelic Therapeutics, Inc. (OTLC) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of -$600.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2024-11-19
- Oncotelic Therapeutics, Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2024-09-30 was -$100.00K.
- Oncotelic Therapeutics, Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2024-06-30 was -$300.00K.
- Oncotelic Therapeutics, Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2024-03-31 was -$200.00K.
- Oncotelic Therapeutics, Inc. cash provided by (used in) operating activities, discontinued operations for fiscal 2023 was -$1.30M.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month |
|---|---|---|---|---|
| 2024-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | -$400.00K derived: sum of 2 quarters · filed 2024-11-19 | -$600.00K 10-Q · filed 2024-11-19 | |
| 2024-06-30 | -$300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$500.00K 10-Q · filed 2024-08-14 | ||
| 2024-03-31 | -$200.00K 10-Q · filed 2024-05-15 | |||
| 2023-12-31 | -$1.30M 10-K · filed 2024-04-12 |